Bioanalytical Laboratories

 

Phase I / Bioequivalence

About PharmaNet Laboratories

 

Capabilities

Our Equipment

Sample Handling

Method Development and Validation

Sample Analysis

Discovery Support

Biomarkers

ELISA and RIA

ICP / MS

List of Available Assays and Biomarkers

 

About Our Companies

Anapharm

Anapharm Europe

Keystone Analytical

Taylor Technology

Phase I / Bioequivalence

 

About Anapharm

Overview

Phase I Studies

Generic-Drug / Bioequivalence Studies

Services

Experience

Special Populations

Therapeutic Areas

Equipment and Software

Project Management

Quality Assurance

QT / QTc Capabilities

Clinical Laboratory

Clinical Pharmacology

Regulatory / Scientific Affairs

Regulatory / Scientific and Medical Writing

     
     
Consulting   Phase II–IV

Consulting Services

 

Clinical and Product Development

International Regulatory Consultation

Clinical Development Planning

Global Safety and Pharmacovigilance

Risk Management

Gap Analysis

Submission Strategies

Regulatory Liaison

Biostatistics

Pharmacokinetics and Pharmacodynamics

 

Key Product Areas

Biosimilars

Blood

Cell / Gene Therapies

Combination Products

Drug Delivery Systems

Medical Devices

Small Molecule Drug Products

Therapeutic Proteins

Vaccines

 

Business Plan Services

Business Plan Services

 

Life Sciences Investments

Life Sciences Investments

 

Chemistry / Manufacturing Controls

Regulatory Strategies

Implementation Consultation

 

Quality Assurance / Quality Control

SOP Development

FDA Inspection (GxP)

Process Validation

GxP Training / Audits

Quality Systems Regulation

 

Library

Presentations

Case Studies

Conference / Events

 

Phase II–IV Overview

 

Services

Bioanalytical Laboratory

Biostatistics

Data Management

Global Safety and Pharmacovigilance

Medical Writing

Project Management

Protocol / Case Report Form Design

Quality Control / Assurance

Regulatory Affairs

Risk Management

Site Management

Strategic Planning

Study Monitoring

 

Specialty Areas

Our Approach

Dermatology

General Medicine and Cardiovascular

Infectious Disease and Vaccines

Neuroscience

Oncology

Ophthalmology

Pediatrics

Women's Health

 

Phase IV Development

Phase IV Development

 

Clinical Recruitment

Overview

Program Branding

Effective Database Search

Consistent Study Communications

Study-Specific Web Portal

Professional Referral-Network Mgt

Program-Awareness Materials

Advertising and Public Announcements

Sample List of Deliverables

Additional Programs and Materials

   
   
Technology (About PharmaSoft)   Investors

The Integral Difference of PharmaSoft

 

Integral CDMS/CTMS

Integral CDMS / CTMS

 

IVRS

Integrated Voice Response System (IVRS)

Overview

Press Releases

SEC Filings

Stock Information

Interactive Event Calendar

Investor Services

Corporate Information

Governance

EDC  

Electronic Data Capture (EDC)

About Us

 
Dictionary Coding About PharmaNet
Dictionary Coding
Management Team
 

Office Locations

Laboratory Data Management    
Laboratory Data Management Careers
 
Safety Data Management   Careers
Safety Data Management
 
  News
PharmaSoft Case Studies  
1. Hybrid Data Capture News
2. Managing Patient Endpoints  
    Investigators
Support Service
Support Services Investigators
     
In-House Tools   Study Participants
In-House Tools
  Study Participants
   
Biologics / Biosimilars   Contact Us
Biologics / Biosimilars   Contact Us
     
About Our Relevant Subsidiaries and Partners    
Anapharm    
PharmaNet    
Taylor Technology    
Novatia    
     
Overview    
Overview    
     
Services    
Analytical Structure Assessments    
Cell-based Assay    
Consulting    
Data Management    
ELISA and RIA    
Immunogenicity Assay    
Pharmacovigilance    
Phase I    
Phase II / III    
Post-Marketing    
     
PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390